SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-15-037107
Filing Date
2015-10-07
Accepted
2015-10-07 18:03:31
Documents
2
Period of Report
2015-10-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 4245
2 efc15-671_ex241.htm EX-24.1 13884
  Complete submission text file 0001140361-15-037107.txt   19553
Mailing Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080
Business Address 650 GATEWAY BLVD. SUITE 125 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Kavanaugh William Michael (Reporting) CIK: 0001578767 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37587 | Film No.: 151149755